Dispatch Bio Funding: $216M Raised, Series A (2024)
Dispatch Bio is a Biotech company based in San Francisco, CA. It has raised $216M in total funding. Latest round: Series A.
Dispatch Bio funding overview
Dispatch Bio is a Biotech company based in San Francisco, CA. Dispatch Bio has raised $216M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in July 2024. The round record for Dispatch Bio runs through 2024; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Parker Institute for Cancer Immunotherapy. 2 distinct backers are named across the disclosed rounds.
Dispatch Bio at a glance
Total raised
$216M
Latest round
Series A
Latest round date
July 2024
Industry
Biotech
Headquarters
San Francisco, CA
Notable investors
ARCH Venture Partners, Parker Institute for Cancer Immunotherapy
Frequently asked about Dispatch Bio funding
How much has Dispatch Bio raised?
Dispatch Bio has raised $216M in total disclosed funding across the rounds on record.
Who has invested in Dispatch Bio?
ARCH Venture Partners, Parker Institute for Cancer Immunotherapy are named among the investors backing Dispatch Bio.
What was the latest Dispatch Bio funding round?
The most recent disclosed round is a Series A, announced in July 2024.
Where is Dispatch Bio based?
Dispatch Bio is based in San Francisco, CA.
What sector does Dispatch Bio operate in?
Dispatch Bio is tracked under Biotech from San Francisco, CA, with $216M in disclosed funding.
When did Dispatch Bio last raise?
The last disclosed Dispatch Bio round closed in July 2024 at Series A.
Round data for Dispatch Bio is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in San Francisco and backer lists below.
